Study guide

5.1 Elements of a Valid Massachusetts Prescription

Massachusetts MPJE Pharmacy Jurisprudence Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Federal Drug Law & Regulatory Foundations

1.1 Federal Acts & Agencies 1.2 Drug Supply Chain Security & Adulteration/Misbranding 1.3 Poison Prevention & Special Packaging Standards

2 Chapter 2: Federal Controlled Substances Act (CSA) Governance

2.1 CSA Scheduling, Registration & Ordering 2.2 Controlled Substance Inventory, Theft & Disposal 2.3 Corresponding Responsibility & DEA Red Flags

3 Chapter 3: Massachusetts Board Authority, Licensure & Continuing Education

3.1 Board of Registration in Pharmacy: Structure & Enforcement 3.2 Pharmacist Licensure, Reciprocity & Renewal 3.3 Continuing Education Requirements

4 Chapter 4: Massachusetts Pharmacy Personnel & Supervision

4.1 Pharmacy Interns: Licensure, Hours & Preceptors 4.2 Pharmacy Technician Licensure Tiers & Scope 4.3 Supervisory Ratios & Direct Supervision 4.4 Manager of Record: Duties, Appointment & Reporting

5 Chapter 5: Prescription Validity, Prescriber Authority & Opioid Limits

5.1 Elements of a Valid Massachusetts Prescription 5.2 Prescriber Authority & the Massachusetts Controlled Substances Registration 5.3 The Massachusetts Electronic Prescribing Mandate 5.4 M.G.L. c. 94C, Massachusetts Schedules & Prescription Validity Windows 5.5 Opioid Prescribing Limits & Partial Fill Rights

6 Chapter 6: Refills, Transfers, Recordkeeping & Emergency Dispensing

6.1 Refill Limits, Sequential Schedule II Prescriptions & Partial Fills 6.2 Prescription Transfers & Pharmacy Recordkeeping 6.3 Out-of-State Prescriptions 6.4 Emergency Dispensing: Oral Schedule II Orders & Schedule VI Emergency Supplies

7 Chapter 7: Product Selection, Labeling & Patient Care Standards

7.1 Mandatory Interchange & the Massachusetts List of Interchangeable Drug Products 7.2 Container Labeling, MedGuides & Patient Package Inserts 7.3 Patient Counseling, Profiles & Drug Utilization Review 7.4 Pharmacist Administration of Drugs & Vaccines 7.5 Returning, Reusing & Disposing of Dispensed Drugs

8 Chapter 8: MassPAT, Nonprescription Products, Public Health & Privacy

8.1 MassPAT: Prescription Monitoring Program Query & Reporting 8.2 Naloxone, Syringes & Standing Orders 8.3 Patient Privacy (HIPAA) & Massachusetts Privacy Rules 8.4 Nonprescription, Behind-the-Counter & Restricted OTC Products

9 Chapter 9: Pharmacy Facilities, Security, Automation & Quality

9.1 Pharmacy Licensure, Facilities & Required References 9.2 Continuous Quality Improvement & Quality Related Events 9.3 Pharmacy Practice Automation & Automated Dispensing Devices 9.4 Security, Delivery, Central Fill & Non-Resident Practice

10 Chapter 10: Compounding, Hazardous Drugs & Expanded Pharmacist Practice

10.1 Non-Sterile Compounding: USP <795> & the Massachusetts Overlay 10.2 Sterile Compounding: USP <797> & the Massachusetts Overlay 10.3 Hazardous Drugs & USP <800> 10.4 Collaborative Drug Therapy Management

11 Chapter 11: The MPJE Blueprint, Delivery & Scoring

11.1 How the MPJE Is Built, Delivered and Scored

5.1 Elements of a Valid Massachusetts Prescription

Key Takeaways Explain This Topic AI

Prescription format and security in Massachusetts is governed by DPH regulation 105 CMR 721.000, alongside M.G.L. c. 94C and the Board's rules at 247 CMR 20.04 and 9.04.

Because Massachusetts Schedule VI covers every non-controlled legend drug, the prescription rules of c. 94C reach ordinary prescriptions and not just federally controlled substances.

247 CMR 9.04 requires customer identification for the dispensing of Schedule II through V controlled substances and requires the NDC of the product actually dispensed to be recorded when a generic is supplied.

A controlled substance prescription must be dated with the actual day it was issued; pre-dating and post-dating are prohibited, although a practitioner may issue sequential Schedule II prescriptions bearing 'do not fill until' instructions.

Final dispensing process validation is reserved by 247 CMR 9.04 to a licensed pharmacist and cannot be delegated to an intern, a technician or an automated system.

Last updated: August 2026

Elements of a Valid Massachusetts Prescription

Three bodies of law converge on the face of a Massachusetts prescription:

Source What it supplies

M.G.L. c. 94C The definition of a prescription, who may issue one, scheduling (including Schedule VI), and the electronic prescribing mandate

105 CMR 721.000 (DPH) Standards for Prescription Format and Security in Massachusetts — the physical and security characteristics of a prescription form

247 CMR 20.04 and 9.04 (Board) Orally and electronically transmitted prescriptions and PMP reporting (20.04, which replaced the now-reserved 247 CMR 5.00); the requirements for dispensing and refilling (9.04)

21 CFR Part 1306 The federal overlay for Schedule II through V substances

Important

Schedule VI changes the scope of everything. Massachusetts places every prescription-only drug that is not in federal Schedules I–V into state Schedule VI . The consequence is that c. 94C's prescription rules — registration, format, electronic transmission, recordkeeping — apply to an amlodipine prescription in the same way they apply to an oxycodone prescription. When a question says "controlled substance" in a Massachusetts context, ask whether it means II–V or II–VI.

  • Core Elements
  • Patient identification

Full name of the ultimate user.

Address , which federal law requires on every controlled substance prescription (21 CFR 1306.05).

For a veterinary prescription, the owner's name and the species of the animal .

Prescriber identification

Full name, professional designation and practice address.

DEA registration number for federally controlled substances (Schedules II–V).

Massachusetts Controlled Substances Registration (MCSR) number — the state registration issued by the DPH Drug Control Program under M.G.L. c. 94C, § 7 . Because Schedule VI is a state controlled-substance schedule, the MCSR requirement is not limited to practitioners who prescribe federally controlled drugs.

Drug and directions

Drug name, strength and dosage form.

Quantity to be dispensed.

Explicit directions for use. "Take as directed" is not adequate for a controlled substance; the pharmacist cannot construct a compliant container label from it.

Number of refills authorised, or an express statement of none.

Date and signature

The prescription must bear the actual date on which it was issued . Pre-dating and post-dating are prohibited under 21 CFR 1306.05.

A manual signature on a paper controlled substance prescription; a compliant EPCS digital signature with two-factor authentication on an electronic one.

Warning

"Do not fill until" is not post-dating. A practitioner may lawfully issue multiple sequential Schedule II prescriptions on the same day, together providing up to a 90-day supply, each bearing the true date of issuance plus written instructions giving the earliest date on which it may be filled. The issuance date stays honest; only the fill date moves.

Massachusetts-specific requirements at the counter — 247 CMR 9.04

The Board's dispensing standards add obligations that do not exist federally and that candidates frequently overlook:

Customer identification. 247 CMR 9.04 imposes identification requirements on the dispensing of controlled substances in Schedules II through V . The pharmacy must be able to establish who received the medication.

Record the NDC actually dispensed. When a generic product is supplied, the National Drug Code of the product dispensed must be documented — which is what makes the interchange record in M.G.L. c. 112, § 12D auditable.

Final dispensing process validation is the pharmacist's. 247 CMR 9.04 states that a licensed pharmacist is responsible for final dispensing process validation. No technician tier, no intern and no automated system performs it.

Computerised patient profiles. The pharmacy must process prescriptions and maintain patient profiles through a computerised pharmacy system, with defined procedures for system downtime — recording what happened during the outage in the patient's medication profile once the system returns, preserving continuity of care, and performing an appropriate drug utilization review.

Who May Transmit and Receive

Transmission Who may receive it in Massachusetts

Written or electronic Any pharmacy staff member may take physical custody, but the pharmacist performs final validation

Oral order, Schedule VI Pharmacist, pharmacy intern, or certified pharmacy technician with the pharmacist's approval (247 CMR 8.04(4)(c))

Oral order, Schedules II–V Pharmacist or pharmacy intern only

Refill authorisation, nothing changed Pharmacist, intern, certified technician, or pharmacy technician with the pharmacist's approval (247 CMR 8.02(6)(c))

  • Any prescription, by a pharmacy technician trainee by telephone Prohibited (247 CMR 8.03(4)(c))
  • Worked Traps

A prescription for lisinopril arrives with no MCSR number. Massachusetts Schedule VI means this is a controlled substance prescription under state law; the prescriber needs a current MCSR. Verify before dispensing.

A paper Schedule II prescription is signed with a signature stamp. Invalid — a manual signature is required.

Three oxycodone prescriptions are written the same day, dated over three consecutive months. Invalid as written. The sequential-prescription rule requires each to carry the true issuance date with a separate "do not fill until" instruction.